Barnett A J, Taubman I
Med J Aust. 1976 Oct 9;2(15):563-6. doi: 10.5694/j.1326-5377.1976.tb130388.x.
Drug fashions have changed and older drugs have given place to others with less side effects. Drugs and combinations of drugs administered to 100 patients currently under treatment at a clinic for severe hypertensives are listed. The most popular drugs were thiazide diuretics, methyldopa, beta-adrenergic blocking drugs, clinidine and hydrallazine. A thiazide diuretic was a constant member of the drug combinations. About 60% of patients achieved "good" blood pressure control (diastolic blood pressure less than or equal to 100 mm Hg), 30% "fair" (diastolic blood pressure=100 to 110 mm Hg) and 10+ "poor" (diastolic blood pressure greater than 110 mm Hg). Similar proportions were in "good", "fair" and "poor" general health. The best prospect for improved management of hypertension probably lies in earlier treatment with current drug combinations.
药物流行趋势已经改变,老药已被副作用较小的其他药物所取代。列出了目前在一家重症高血压诊所接受治疗的100名患者所使用的药物及药物组合。最常用的药物是噻嗪类利尿剂、甲基多巴、β-肾上腺素能阻滞剂、可乐定和肼屈嗪。噻嗪类利尿剂是药物组合中的固定成分。约60%的患者血压得到“良好”控制(舒张压小于或等于100毫米汞柱),30%为“一般”(舒张压为100至110毫米汞柱),10%以上为“较差”(舒张压大于110毫米汞柱)。“良好”“一般”和“较差”的总体健康状况比例相似。改善高血压管理的最佳前景可能在于使用目前的药物组合进行早期治疗。